Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mapping interventions addressing frailty and associated outcomes in people with heart failure: a scoping review.

BMJ open·2026

Same author

Validation of the modified transplant symptom occurrence and symptom distress scale and exploring symptom burden in Brazilian kidney transplant recipients.

Scientific reports·2026

Same author

Person-Level Correlates of Nonadherence to Co-Medication in Spanish Heart Transplant Recipients.

Western journal of nursing research·2026

Same author

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trial.

Trials·2026

Same author

Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non-Relapse Mortality.

European journal of haematology·2026

Same author

How to bring nurse-led eHealth symptom monitoring in daily care: the Belgian SMILe integrated care model for allogeneic stem cell transplantation adaptation project.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

[Medication non adherence - predictive factors and diagnostics].

Petra Schäfer-Keller¹, Daniela Garzoni, Michael Dickenmann

¹Institut für Pflegewissenschaft, Universität Basel.

Therapeutische Umschau. Revue Therapeutique

|June 1, 2010

Summary

This summary is machine-generated.

Assessing medication non-adherence is complex, as no gold standard exists. This study proposes a two-step approach: initial screening followed by in-depth interviews for non-adherent patients, leading to tailored support.

Related Experiment Videos

Last Updated: Jun 12, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Health Services Research
Patient Adherence Studies
Clinical Psychology

Background:

Medication non-adherence presents multifaceted challenges in healthcare.
A universally accepted gold standard for assessing medication non-adherence is currently lacking.
Existing frameworks, like the WHO's five dimensions and NICE guidelines, offer valuable insights into adherence factors.

Purpose of the Study:

To identify key factors associated with medication non-adherence.
To propose a practical, two-step assessment strategy for clinical settings.
To bridge the gap between adherence assessment and effective patient support.

Main Methods:

Review of current research on medication non-adherence factors.
Integration of the World Health Organization's five adherence dimensions.
Incorporation of subjective patient appraisal methods, such as those suggested by NICE.
Proposal of a two-stage assessment: routine screening and in-depth interviews.

Main Results:

Medication non-adherence is influenced by a complex interplay of factors.
A structured, two-step assessment process can effectively identify non-adherence.
Routine screening via patient self-report, supplemented by other evidence, is a viable first step.
In-depth interviews are crucial for patients exhibiting initial signs of non-adherence.

Conclusions:

A practical, two-step adherence assessment model is proposed for clinical implementation.
Adherence assessment should seamlessly transition into adherence support strategies.
Effective adherence management requires a collaborative partnership between patients and healthcare professionals.
Achieving medication adherence, especially in complex cases, is an incremental, staged process.